Skip to main content
. 2015 May 28;10(5):e0127776. doi: 10.1371/journal.pone.0127776

Fig 2. Relative levels of DREAM in the retina.

Fig 2

(a) Western blot analysis performed by using antibodies against DREAM and TATA binding protein indicate that DREAM expressed constitutively in retinal nuclear proteins extracted from PBS-treated eyes was reduced in proteins extracted from NMDA-treated eyes. (b) Semi-quantitative analysis of western blots indicate a significant decrease in DREAM levels in retinal protein extracted from NMDA-treated eyes when compared to PBS-treated eyes. *p<0.05. (c) EMSA assays show that the binding of DREAM to DRE oligonucleotides was decreased in retinal nuclear proteins extracted from NMDA-treated eyes (horizontal arrow), when compared to PBS-treated eyes.